TABLE VI.
Vaccination-triggered anaphylaxis cases by vaccine exposures (n = 33)
| Vaccine | Alone | With other vaccines |
Other concomitant vaccine(s)* |
|---|---|---|---|
| TIV | 10 | 4 | MIV, Tdap (2), PPSV23 |
|
| |||
| MIV | 2 | 1 | TIV |
|
| |||
| Tdap | 1 | 8 | TIV (2), HPV4, HAV, VAR, MCV4+MMRV, MCV4+VAR, MCV4+VA R +HAV |
|
| |||
| PPSV23 | 1 | 1 | TIV |
|
| |||
| HAV | 1 | 3 | Tdap, Tdap+MCV4+VAR, VAR |
|
| |||
| HZV | 2 | 0 | — |
|
| |||
| Rabies | 1 | 0 | — |
|
| |||
| HPV4 | — | 2 | Tdap, MMR+MCV4 |
|
| |||
| MMR | — | 3 | DTaP-IPV+AR, DTaP+IPV+VAR, HPV4+ MCV4 |
|
| |||
| MMRV | — | 2 | Tdap+MCV4, DTaP+IPV |
|
| |||
| MCV4 | — | 4 | Tdap+MMRV, Tdap+VAR, Tdap+VA R + HAV, HPV4+MMR |
|
| |||
| VAR | — | 5 | Tdap, Tdap+MCV4+HAV, DTaP-IPV+ MMR, HAV, Tdap+MCV4 |
|
| |||
| DTaP-IPV | — | 1 | MMR+VAR |
|
| |||
| DTaP | — | 2 | MMRV+IPV, MMR+IPV+VAR |
|
| |||
| IPV | — | 2 | DTaP+MMRV, DTaP+MMR+VAR |
IPV, Inactivated polio vaccine; MCV4, meningococcal conjugate vaccine; MMRV, measles, mumps, rubella, and varicella vaccine; PPSV23, pneumococcal polysaccharide vaccine (23-valent); VAR, varicella vaccine.
*
A total of 15 (45%) cases received 2 or more concomitant vaccines.